Invesco Ltd. Announces September 30, 2025 Assets Under Management
Get Alerts IVZ Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.1%
Revenue Growth %: -15.2%
Join SI Premium – FREE
|
Total Assets Under Management |
|||||||||
|
(in billions) |
Total |
ETFs & Index |
Fundamental |
Fundamental |
Private |
China JV |
Multi- |
Global |
QQQ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 All September numbers preliminary – subject to adjustment. |
About Invesco Ltd.
Invesco Ltd. (NYSE: IVZ) is a global independent investment management firm dedicated to delivering an investment experience that helps people get more out of life. With offices in more than 20 countries, our distinctive investment teams deliver a comprehensive range of active, passive and alternative investment capabilities. For more information, visit www.invesco.com/corporate.
Category: AUM
|
Investor Relations Contacts: |
Greg Ketron |
404-724-4299 |
|
|
Jennifer Church |
404-439-3428 |
|
Media Relations Contact: |
Andrea Raphael |
212-323-4202 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/invesco-ltd-announces-september-30-2025-assets-under-management-302580050.html
SOURCE Invesco Ltd.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- T. ROWE PRICE GROUP REPORTS MONTH-END ASSETS UNDER MANAGEMENT FOR AUGUST 2026
- Tessera Begins Trading Under HLSQ as Demand Grows for Connected Physical Security
- Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share